MAR 13, 2015 4:44 PM PDT

A Good Night's Sleep Does More Than Prevent Yawning

WRITTEN BY: Ilene Schneider
New research from The Scripps Research Institute (TSRI) shows that two proteins critical for maintaining healthy day-night cycles also protect against mutations that could lead to cancer.

The new study, published March 10, 2015, in the journal eLife, shows that the two proteins have an unexpected role in DNA repair, possibly protecting cells from cancer-causing mutations triggered by UV radiation.

"These proteins play an important role in the response to DNA damage," said TSRI biologist Katja Lamia, senior author of the study. "Researchers might eventually harness that knowledge for pharmaceutical targeting."

Day and Night

The human body senses light and adjusts its rhythms to a day-night cycle called the circadian clock. Feeling tired? Feeling hungry? These feelings are strongly influenced by the body's circadian clock.

Studies show that people with unusual sleep schedules, such as flight attendants or night-shift nurses, are at risk for certain health problems.

"When you have a deregulation of your circadian clock, you're more prone to develop some kind of pathology, like diabetes, cancer or heart disease," said TSRI Research Associate Anne-Laure Huber, who was co-first author of the study with Stephanie Papp, a graduate student at TSRI.

In the new study, the research team investigated a possible cause of these health disparities. They focused on the role of proteins called cryptochromes, which are believed to have evolved from light-activated DNA repair enzymes in bacteria.

Cryptochromes contain a photo-responsive pigment called flavin. While cryptochromes are no longer light-activated, they do hold to a daytime-regulated schedule, and stability of the proteins cryptochrome 1 (Cry1) and cryptochrome 2 (Cry2) is critical for circadian clock function. In the human body, cryptochromes no longer have a direct role in DNA repair either, but they are essential for regulating blood sugar levels and protein production on a day-night cycle.

Repairing DNA

The new study started when the researchers went on what Lamia calls a "fishing expedition." They used a technique called proteomic screening, in collaboration with the laboratory of TSRI Professor John Yates, to test for a wide range of proteins that could bind to Cry1 or Cry2 from mouse and human cells.

The team found that Cry1 could bind with Hausp, a protein with a known role in regulating an anti-cancer protein called p53. The screening also showed that Hausp binds to Cry2, but not as strongly, suggesting that the nearly identical proteins actually have different roles related to DNA repair.

"Most of the time people study them as redundant proteins, but we show that they have distinct functions in this DNA-repair pathway," said Lamia.

Subsequent studies of genetic expression showed that Hausp stabilizes Cry1 by removing protein chains that trigger Cry1 degradation. By stabilizing Cry1, Hausp prevents potential errors in DNA transcription that could occur when DNA is exposed to radiation.

"This is very cool," said Papp. "These proteins can sense that something is wrong in the cells."

The researchers also found that when they blocked Cry2 production in cells, the cells no longer activated p21, a protein that stops mutant cells from dividing. "This could suggest that cells without Cry2 would be more susceptible to cancer," said Lamia.

Together, these findings show that while Cry1 and Cry2 no longer directly repair DNA, they still have an indirect role in the repair process.

This new link between circadian clock proteins and DNA repair is a clue to how disrupting day-night cycles could harm health. Lamia said future studies in her lab will explore additional roles of cryptochromes in the body.

Source: TSRI
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
DEC 02, 2019
Drug Discovery & Development
DEC 02, 2019
New Ultrasound Treatment for Parkinson's Tremors
A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), accord...
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries
Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of re...
DEC 29, 2019
Cell & Molecular Biology
DEC 29, 2019
How close are we to a simple blood test for Parkinson's Disease?
Parkinson’s Disease (PD) alters nerve cells in the brain that produce the neurotransmitter dopamine. Famously regarded as the “happiness”...
JAN 03, 2020
Neuroscience
JAN 03, 2020
Natural Smells Effective in Reducing Stress Levels
For some time now, studies have been abound on the benefits of nature for both physical and mental health. Now, however, research shows that smells derived...
JAN 16, 2020
Neuroscience
JAN 16, 2020
New Wearable that Helps the Body Adapt to Stress
Physicians and neuroscientists at the University of Pittsburgh have developed Apollo- a wearable they claim helps the body adapt to stress, improve sleep q...
FEB 12, 2020
Health & Medicine
FEB 12, 2020
Brain Patients are Advancing Research
Neuroscientists may face the challenge of not having enough material or high-quality material to study the condition they’re researching. Luckily&mda...
Loading Comments...